| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
282.53(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
459,004 |
461,916 |
540,416 |
1,579,317 |
| Total Sell Value |
$81,195,771 |
$81,646,316 |
$93,320,391 |
$252,708,726 |
| Total People Sold |
9 |
9 |
9 |
14 |
| Total Sell Transactions |
10 |
11 |
13 |
37 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hudson Thomas J |
SVP, R&D AND CSO |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
63,023 |
109,251 |
|
- |
|
| Richmond Timothy J. |
EVP, CHIEF HR OFFICER |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
79,252 |
93,089 |
|
- |
|
| Michael Robert A. |
VICE CHAIRMAN |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
109,103 |
146,980 |
|
- |
|
| Siatis Perry C |
EVP, GC AND SECRETARY |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
21,791 |
32,168 |
|
- |
|
| Strom Carrie C |
SVP & PRES GLOBAL ALLERG AESTH |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
11,620 |
52,283 |
|
- |
|
| Saleki-Gerhardt Azita |
EVP, OPERATIONS |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
75,296 |
233,208 |
|
- |
|
| Durkin Brian L |
VP, CONTROLLER |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
25,237 |
44,331 |
|
- |
|
| Gonzalez Richard A |
CHAIRMAN OF THE BOARD AND CEO |
• • – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
256,901 |
760,154 |
|
- |
|
| Sorg Elaine K. |
SVP, US COMMERCIAL OPERATIONS |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
44,803 |
62,679 |
|
- |
|
| Richmond Timothy J. |
EVP, CHIEF HR OFFICER |
• – – |
2022-12-12 |
4 |
S |
$163.39 |
$6,925,018 |
D/D |
(42,370) |
13,837 |
|
1% |
|
| Richmond Timothy J. |
EVP, CHIEF HR OFFICER |
• – – |
2022-12-12 |
4 |
OE |
$54.86 |
$2,324,418 |
D/D |
42,370 |
56,207 |
|
- |
|
| Siatis Perry C |
EVP, GC and Secretary |
• – – |
2022-10-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,377 |
|
8% |
|
| Reents Scott T |
SVP, Chief Financial Officer |
• – – |
2022-06-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
809 |
|
-3% |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-23 |
4 |
S |
$150.79 |
$12,041,780 |
D/D |
(79,801) |
152,103 |
|
7% |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-23 |
4 |
OE |
$93.50 |
$8,697,627 |
D/D |
79,801 |
231,904 |
|
- |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-17 |
4 |
S |
$153.43 |
$15,404,400 |
D/D |
(100,000) |
152,103 |
|
8% |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-17 |
4 |
OE |
$79.02 |
$8,837,929 |
D/D |
100,000 |
252,103 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2022-05-16 |
4/A |
S |
$155.00 |
$13,013,800 |
D/D |
(83,960) |
41,623 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2022-05-16 |
4/A |
OE |
$54.86 |
$4,606,046 |
D/D |
83,960 |
125,583 |
|
- |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-16 |
4 |
S |
$154.04 |
$15,445,089 |
D/D |
(100,000) |
152,103 |
|
9% |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-16 |
4 |
OE |
$61.36 |
$6,650,277 |
D/D |
100,000 |
252,103 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2022-05-16 |
4 |
S |
$155.00 |
$13,013,800 |
D/D |
(83,960) |
16,623 |
|
9% |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2022-05-16 |
4 |
OE |
$54.86 |
$4,606,046 |
D/D |
83,960 |
100,583 |
|
- |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2022-05-11 |
4 |
D |
$152.09 |
$437,411 |
D/D |
(2,876) |
40,663 |
|
- |
|
| Severino Michael |
Vice Chairman |
• – – |
2022-05-10 |
4 |
S |
$151.16 |
$15,227,966 |
D/D |
(100,000) |
152,103 |
|
7% |
|
641 Records found
|
|
Page 5 of 26 |
|
|
7.67 (4.58%) 
